Search results
2021 Annual Report. 2022 Proxy Statement. The Investor Relations website contains information about Abbott Laboratories's business for stockholders, potential investors, and financial analysts.
- Stock Prices
Annual Reports; Financial Snapshot; SEC Filings; Stock...
- SEC Filings
Report of unscheduled material events or corporate event....
- Investment Calculator
Investment Date Original Shares Original Value Current...
- News & Events
Abbott at the 42nd Annual J.P. Morgan Conference. Click here...
- 2023 ANNUAL REPORT
ABBOTT 2023 ANNUAL REPORT 3 Pipeline Productivity In 2023,...
- Stock Prices
ABBOTT 2023 ANNUAL REPORT 3 Pipeline Productivity In 2023, we continued to introduce a robust stream of important new healthcare products. These included: • Alinity TBI, a laboratory test for concussion • Alinity h, an integrated hematology system for advanced testing of complete blood counts • Alinity m high risk HPV, a new test for
ABBOTT 2022 ANNUAL REPORT COMMITTED. For 135 years, Abbott has focused relentlessly on delivering for our stakeholders. Today, billions of people around the world depend on us in vital ways. We’re committed to honoring that trust.
Download the PDF document to read Abbott's letter to shareholders, financial results, and business highlights for 2021. Learn how Abbott met the pandemic challenges with innovation, diversification, and resilience.
ABBOTT 2020 ANNUAL REPORT DEAR FELLOW SHAREHOLDER: In the most challenging year in living memory, Abbott rose to the test, making major contributions to the global effort to defeat COVID-19. This was consistent with our long history, with our values, and with our purpose as a company. We were built for times like these. ROBERT FORD
Today, Abbott is well positioned in markets where healthcare needs are great and growing fast. ABBOTT 2018 ANNUAL REPORT 3
2023 ANNUAL REPORT.
